Back to Results
First PageMeta Content
Matter / Reference dose / Arsenic / Aspirin / No observable adverse effect level / Dose / Median lethal dose / Arsenic trioxide / Toxicology / Chemistry / Medicine


Draft IRIS Summary Do not cite or quoteThis document is in draft form. It has not been formally released by the U.S. Environmental Protection Agency and should not at this stage be construed to represent Agenc
Add to Reading List

Document Date: 2009-12-17 08:58:42


Open Document

File Size: 349,62 KB

Share Result on Facebook

Country

Taiwan / Japan / United States / Argentina / Chile / /

/

IndustryTerm

arsenate solutions / chemical substance / arsenic solution / chemical / food / /

MedicalCondition

blackfoot disease / cancers / encephaloceles / chronic arsenicism / Cancer / aforementioned cancer / primary cancers / hyperpigmentation / lung and bladder cancer / palmar and plantar keratosis / keratosis / ORAL RfD SUMMARY Critical Effect Hyperpigmentation / skin cancer / vascular complications Human Chronic / lung cancer / internal cancers / liver cancer / Exencephaly / viral hepatitis / observed liver cancer / increased cancer / chronic oral exposure / /

Organization

EPA's Risk Assessment Council / Nuclear Regulatory Commission / U.S. Environmental Protection Agency / office of Research and Development / /

Person

Schroeder / /

/

Position

contractor / Carpenter / /

Region

southwest Taiwan / /

URL

http /

SocialTag